Show item record

dc.contributor.authorYang, Xiaoling
dc.contributor.authorBosoi, Cristina R.
dc.contributor.authorJiang, Wenlei
dc.contributor.authorTremblay, Mélanie
dc.contributor.authorRose, Christopher
dc.date.accessioned2013-04-23T16:30:19Z
dc.date.available2013-04-23T16:30:19Z
dc.date.issued2010-03
dc.identifier.urihttp://hdl.handle.net/1866/9572
dc.description.sponsorshipCIHR-MOP-82839en
dc.subjectAnaphylaxie cutanée passiveen
dc.subjectEncéphalopathie hépatiqueen
dc.subjectHepatic encephalopathyen
dc.subjectHyperammonemiaen
dc.subjectHyperammoniémieen
dc.subjectOxidative stressen
dc.subjectPassive cutaneous anaphylaxisen
dc.subjectPCAen
dc.subjectStress oxydatifen
dc.titlePortacaval anastomosis-induced hyperammonemia does not lead to oxidative stress
dc.typeArticleen
dc.contributor.affiliationUniversité de Montréal. Faculté de médecinefr
dc.contributor.affiliationUniversité de Montréal. Faculté de médecine. Centre de recherche du CHUMfr
dc.identifier.doi10.1007/s11011-010-9174-1
dcterms.abstractAmmonia is neurotoxic and believed to play a major role in the pathogenesis of hepatic encephalopathy (HE). It has been demonstrated, in vitro and in vivo, that acute and high ammonia treatment induces oxidative stress. Reactive oxygen species (ROS) are highly reactive and can lead to oxidization of proteins resulting in protein damage. The present study was aimed to assess oxidative status of proteins in plasma and brain (frontal cortex) of rats with 4-week portacaval anastomosis (PCA). Markers of oxidative stress, 4-hydroxy-2-nonenal (HNE) and carbonylation were evaluated by immunoblotting in plasma and frontal cortex. Western blot analysis did not demonstrate a significant difference in either HNE-linked or carbonyl derivatives on proteins between PCA and sham-operated control rats in both plasma and frontal cortex. The present study suggests PCA-induced hyperammonemia does not lead to systemic or central oxidative stress.en
dcterms.languageengen
UdeM.VersionRioxxVersion acceptée / Accepted Manuscript
oaire.citationTitleMetabolic brain disease
oaire.citationVolume25
oaire.citationIssue1
oaire.citationStartPage11
oaire.citationEndPage15


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.